期刊文献+

地塞米松预防兔移植静脉再狭窄的实验研究 被引量:2

Experimental study of dexamethasone on prevention of restenosis in rabbit vein grafts
下载PDF
导出
摘要 目的:观察局部应用地塞米松对新西兰兔自体移植静脉再狭窄的影响,并探讨其可能的作用机制。方法:新西兰兔30只,建立兔自体颈外静脉-颈总动脉移植模型,随机分3组:空白对照组、生物蛋白胶组和地塞米松组。各组动物分别于术后3周测量内膜、中膜厚度及管壁炎性细胞数、周期蛋白(PCNA)阳性细胞率和凋亡细胞阳性率。结果:术后3周,地塞米松组较生物蛋白胶组、空白对照组均明显降低内膜、中膜增生厚度,炎性细胞数减少;生物蛋白胶组较空白对照组也可抑制内膜、中膜厚度增生,3组数据PCNA阳性细胞率、凋亡细胞阳性率差异有统计学意义(P<0.05)。结论:地塞米松在新西兰兔自体静脉移植中能通过抑制局部炎性反应,抑制平滑肌细胞增殖、促使血管平滑肌细胞凋亡,从而防止移植静脉再狭窄。 Objective:To observe the effect of dexamethasone on the restenosis of autologous vein graft in New Zealand rabbits,and to explore its possible mechanism.Methods:30New Zealand rabbits were selected.A rabbit model of autogenous external jugular vein graft was established.They were randomly divided into the3groups:the blank control group,the fibrin glue group,and the dexamethasone group.The intima media thickness,the number of inflammatory cells,the number of circulating cells(PCNA)and the positive rate of apoptotic cells were measured at3weeks postoperatively of all animals.Results:At3weeks after operation,the thickness of intima and media was significantly lower in the dexamethasone group than that in the fibrin glue group and the control group,and the number of inflammatory cells decreased.Compared with the blank control group,the fibrin glue group inhibited the proliferation of intima and media thickness,and the positive rate of PCNA positive cells and apoptotic cells were significantly different among the3groups,with statistically significant(P<0.05).Conclusion:Dexamethasone can inhibit local inflammatory response and the proliferation of vascular smooth muscle cells and promote the apoptosis of vascular smooth muscle cells,which can prevent the restenosis of vein grafts.
作者 凌林 胡名松 Ling Lin;Hu Mingsong(The Second Hospital Affiliated to Nanhua University(Hengyang City,Hunan Province)421001)
出处 《中国社区医师》 2017年第14期5-5,7,共2页 Chinese Community Doctors
关键词 地塞米松 生物蛋白胶 再狭窄 增殖 凋亡 Dexamethasone Fibrin glue Restenosis Proliferation Apoptosis
  • 相关文献

参考文献1

二级参考文献10

  • 1Veldkamp RF,Valk SD,Van Domburg RT,et al.Mortality andrepeat interventions up until 20 years after aorto-coronary bypasssurgery with saphenous vein grafts.A follow-up study of 1041 pa-tients.Eur Heart J,2000,21:747-753.
  • 2Brilakis ES,Rao SV,Banerjee S,et al.Percutaneous coronaryintervention in native arteries versus bypass grafts in prior coro-nary artery bypass grafting patients:a report from the NationalCardiovascular Data Registry.JACC Cardiovasc Interv,2011,4:844-850.
  • 3Hong YJ,Jeong MH,Ahn Y,et al.Impact of lesion location onintravascular ultrasound findings and short-term and five-yearlong-term clinical outcome after percutaneous coronary interven-tion for saphenous vein graft lesions.Int J Cardiol,2011,[Epubahead of print].
  • 4Parang P,Arora R.Coronary vein graft disease:pathogenesisand prevention.Can J Cardiol,2009,25:e57-62.
  • 5Silva JA,White CJ,Collins TJ,et al.Morphologic comparisonof atherosclerotic lesions in native coronary arteries and saphenousvein graphs with intracoronary angioscopy in patients with unsta-ble angina.Am Heart J,1998,136:156-163.
  • 6Kaplan S,Barlis P,Kiris A,et al.Immediate procedural andlong-term clinical outcomes following drug-eluting stent implanta-tion to ostial saphenous vein graft lesions.Acute Card Care,2008,10:88-92.
  • 7Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention.Areport of the American college of cardiology foundation/Americanheart association task force on practice guidelines and the societyfor cardiovascular angiography and interventions.J Am Coll Car-diol,2011,58:e44-122.
  • 8Swaminathan A,Stone GW,Rogers C,et al.Influence of vesseldiameter on the efficacy of distal protection devices during saphe-nous vein graft intervention.Am J Cardiol,2005,95:651-654.
  • 9Wiisanen ME,Abdel-Latif A,Mukherjee D,et al.Drug-elutingstents versus bare-metal stents in saphenous vein graft interven-tions:a systematic review and meta-analysis.JACC CardiovascInterv,2010,3:1262-1273.
  • 10Hakeem A,Helmy T,Munsif S,et al.Safety and efficacy ofdrug eluting stents compared with bare metal stents for saphenousvein graft interventions:a comprehensive meta-analysis of ran-domized trials and observational studies comprising 7,994 pa-tients.Catheter Cardiovasc Interv,2011,77:343-355.

共引文献10

同被引文献8

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部